All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-1022-LX805 | Anti-TAG72 (X10X637) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X637 | mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX806 | Anti-TAG72 (X10X638) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X638 | mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX807 | Anti-TAG72 (X10X639) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X639 | Humanized | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX808 | Anti-TAG72 (X10X640) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X640 | Humanized | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX809 | Anti-TAG72 (X10X641) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X641 | Humanized | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX810 | Anti-TAG72 (X10X642) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X642 | Humanized | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1459 | Anti-TAG72 (X10X637) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X637 | mouse | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1460 | Anti-TAG72 (X10X638) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X638 | mouse | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1461 | Anti-TAG72 (X10X639) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X639 | Humanized | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1462 | Anti-TAG72 (X10X640) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X640 | Humanized | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1463 | Anti-TAG72 (X10X641) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X641 | Humanized | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1464 | Anti-TAG72 (X10X642) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X642 | Humanized | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX2113 | Anti-TAG72 (X10X637) h(CD28-41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X637 | mouse | scFv-CD28-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX2114 | Anti-TAG72 (X10X638) h(CD28-41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X638 | mouse | scFv-CD28-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX2115 | Anti-TAG72 (X10X639) h(CD28-41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X639 | Humanized | scFv-CD28-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX2116 | Anti-TAG72 (X10X640) h(CD28-41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X640 | Humanized | scFv-CD28-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX2117 | Anti-TAG72 (X10X641) h(CD28-41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X641 | Humanized | scFv-CD28-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX2118 | Anti-TAG72 (X10X642) h(CD28-41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X642 | Humanized | scFv-CD28-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-0323-ZP773 | Anti-TAG72 (CC49 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | CC49 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0823-LX88 | Anti-hTAG72 (49) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | 49 | Adenoviral vectors | |||||
XS-0923-LX101 | Anti-hTAG72 (CD28-41BB-CD3ζ) CAR-duplex CTLA4 pCDCAR1 Vector | Human | X9X-70 | scFv-CD28-41BB-CD3ζ-duplex CTLA4 | Lentiviral vector | T cell | CAR-T |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION